ClinicalTrials.gov record
Completed Phase 3 Interventional

Two-Dose Methotrexate for Ectopic Pregnancy

ClinicalTrials.gov ID: NCT00194272

Public ClinicalTrials.gov record NCT00194272. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00194272
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Pennsylvania
Other
Enrollment
100 participants

Conditions and interventions

Interventions

  • Methotrexate Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2001
Primary completion
Not listed
Completion
May 31, 2007
Last update posted
Aug 8, 2011

2001 – 2007

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
University of Southern California Women's and Children's Hospital Los Angeles California 90033
University of Miami Miami Florida 33101
University of Pennsylvania Reproductive Research Unit Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00194272, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 8, 2011 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00194272 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →